AMC Entertainment
GameStop
Zomedica
Churchill Capital Corp IV
Ideanomics
Nokia
QuantumScape
Ford Motor
Aphria
Bristol-Myers Squibb (BMY) stock Forecast for 2023, 2024, 2025, 2026
The forecast has been updated: October 3, 2023 5:52
Bristol-Myers stock price online today
Analyst Target Price
72.5Dividend Date
01.11.2023Ex Dividend Date
05.10.2023Last Split Factor
Last Split Date
01.01.1970Should you buy or sell Bristol-Myers stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2023, 2024, 2025?
We predict the dynamics of the stock market value using resonant artificial intelligence systems.
Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.
Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.
Forecasts are adjusted once a day taking into account the price change of the previous day.
To date, analysts have a $72.5 target price for Bristol-Myers stock stock.
Today 200 Day Moving Average is the resistance level (67.17 $).
50 Day Moving Average is the resistance level (61.21 $).
Bristol-Myers stock monthly Forecast
| Date | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| 05 Oct 23 | 61.94 | 61.30 | 62.32 | 1.65 % |
| 06 Oct 23 | 62.23 | 61.61 | 62.51 | 1.46 % |
| 07 Oct 23 | 62.28 | 61.93 | 62.62 | 1.11 % |
| 08 Oct 23 | 61.79 | 61.13 | 62.46 | 2.18 % |
| 09 Oct 23 | 61.70 | 61.16 | 62.12 | 1.57 % |
| 10 Oct 23 | 62.53 | 61.88 | 63.04 | 1.87 % |
| 11 Oct 23 | 62.21 | 61.89 | 62.42 | 0.86 % |
| 12 Oct 23 | 62.17 | 61.49 | 62.61 | 1.81 % |
| 13 Oct 23 | 63.04 | 62.52 | 63.74 | 1.95 % |
| 14 Oct 23 | 63.18 | 62.85 | 63.85 | 1.58 % |
| 15 Oct 23 | 63.62 | 62.91 | 64.17 | 2.00 % |
| 16 Oct 23 | 63.56 | 63.34 | 63.78 | 0.69 % |
| 17 Oct 23 | 63.18 | 62.62 | 63.36 | 1.17 % |
| 18 Oct 23 | 63.98 | 63.32 | 64.32 | 1.57 % |
| 19 Oct 23 | 63.60 | 62.91 | 64.05 | 1.81 % |
| 20 Oct 23 | 63.91 | 63.40 | 64.29 | 1.40 % |
| 21 Oct 23 | 64.55 | 64.27 | 64.91 | 1.00 % |
| 22 Oct 23 | 64.22 | 63.92 | 64.73 | 1.27 % |
| 23 Oct 23 | 64.00 | 63.30 | 64.56 | 2.00 % |
| 24 Oct 23 | 63.84 | 63.25 | 64.23 | 1.54 % |
| 25 Oct 23 | 64.24 | 63.75 | 64.83 | 1.69 % |
| 26 Oct 23 | 64.39 | 63.92 | 65.01 | 1.71 % |
| 27 Oct 23 | 64.74 | 64.23 | 65.12 | 1.38 % |
| 28 Oct 23 | 65.27 | 64.97 | 65.89 | 1.42 % |
| 29 Oct 23 | 66.10 | 65.73 | 66.44 | 1.08 % |
| 30 Oct 23 | 65.69 | 65.51 | 66.24 | 1.12 % |
| 31 Oct 23 | 65.32 | 64.90 | 65.62 | 1.10 % |
| 01 Nov 23 | 65.74 | 65.52 | 66.37 | 1.29 % |
| 02 Nov 23 | 65.67 | 65.30 | 66.06 | 1.15 % |
| 03 Nov 23 | 64.94 | 64.64 | 65.34 | 1.08 % |
BMY daily forecast for this month
Estimated Average Forecasted Bristol-Myers Price: 61.94 Positive intraday dynamics of the instrument is expected with 1.628% volatility is expected.
Pessimistic forecast: 61.30
Optimistic: 62.32
Bristol-Myers stock forecast for 06.10.2023.
Estimated Average Forecasted Bristol-Myers Price: 62.23 Positive intraday dynamics of the instrument is expected with 1.436% volatility is expected.
Pessimistic forecast: 61.61
Optimistic: 62.51
Bristol-Myers stock forecast for 07.10.2023.
Estimated Average Forecasted Bristol-Myers Price: 62.28 Positive intraday dynamics of the instrument is expected with 1.100% volatility is expected.
Pessimistic forecast: 61.93
Optimistic: 62.62
Bristol-Myers stock forecast for 08.10.2023.
Estimated Average Forecasted Bristol-Myers Price: 61.79 Negative intraday dynamics of the instrument is expected with 2.133% volatility is expected.
Pessimistic forecast: 61.13
Optimistic: 62.46
Bristol-Myers stock forecast for 09.10.2023.
Estimated Average Forecasted Bristol-Myers Price: 61.70 Negative intraday dynamics of the instrument is expected with 1.543% volatility is expected.
Pessimistic forecast: 61.16
Optimistic: 62.12
BMY Forecast for 2023
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Oct | 63.21 | 60.53 | 63.94 | 5.33 % |
| Nov | 65.33 | 64.47 | 66.55 | 3.13 % |
| Dec | 66.45 | 65.60 | 68.75 | 4.57 % |
Bristol-Myers stock forecast for this year
Bristol-Myers share price average forecast for Oct 2023 is: 63.2107 The dynamics are positive.
Bristol-Myers share price average forecast for Nov 2023 is: 65.3314 The dynamics are positive.
Bristol-Myers share price average forecast for Dec 2023 is: 66.4453 The dynamics are positive.
Bristol-Myers stock Forecast for 2024
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 63.45 | 61.18 | 65.54 | 6.66 % |
| Feb | 64.15 | 62.24 | 66.19 | 5.97 % |
| Mar | 63.30 | 62.43 | 64.97 | 3.91 % |
| Apr | 66.12 | 63.54 | 67.39 | 5.72 % |
| May | 64.41 | 63.45 | 65.62 | 3.29 % |
| Jun | 64.38 | 62.04 | 66.85 | 7.20 % |
| Jul | 66.50 | 65.07 | 69.24 | 6.02 % |
| Aug | 63.83 | 61.93 | 65.87 | 5.97 % |
| Sep | 65.20 | 64.05 | 67.96 | 5.75 % |
| Oct | 67.39 | 65.64 | 69.72 | 5.85 % |
| Nov | 68.20 | 67.41 | 69.33 | 2.76 % |
| Dec | 70.00 | 68.50 | 70.85 | 3.31 % |
Bristol-Myers stock Forecast for 2025
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 71.97 | 70.74 | 73.63 | 3.92 % |
| Feb | 71.13 | 68.94 | 72.39 | 4.76 % |
| Mar | 69.80 | 68.08 | 71.95 | 5.39 % |
| Apr | 72.22 | 71.27 | 74.57 | 4.42 % |
| May | 71.71 | 68.79 | 73.76 | 6.74 % |
| Jun | 70.09 | 68.12 | 72.63 | 6.21 % |
| Jul | 70.48 | 69.16 | 73.38 | 5.76 % |
| Aug | 69.08 | 67.86 | 71.55 | 5.15 % |
| Sep | 72.46 | 70.43 | 73.90 | 4.69 % |
| Oct | 72.38 | 70.99 | 74.21 | 4.35 % |
| Nov | 72.42 | 71.54 | 74.73 | 4.26 % |
| Dec | 72.98 | 70.21 | 75.27 | 6.72 % |
Bristol-Myers stock Forecast for 2026
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 71.81 | 68.66 | 72.60 | 5.44 % |
| Feb | 71.06 | 68.88 | 74.03 | 6.97 % |
| Mar | 71.96 | 68.88 | 75.01 | 8.18 % |
| Apr | 68.32 | 65.65 | 71.22 | 7.81 % |
| May | 69.98 | 67.59 | 70.86 | 4.62 % |
| Jun | 72.59 | 69.88 | 75.59 | 7.55 % |
| Jul | 71.00 | 69.98 | 73.57 | 4.88 % |
| Aug | 73.85 | 71.77 | 76.81 | 6.56 % |
| Sep | 72.10 | 71.15 | 74.24 | 4.17 % |
| Oct | 74.80 | 71.63 | 75.70 | 5.38 % |
| Nov | 73.60 | 72.75 | 76.56 | 4.97 % |
| Dec | 77.00 | 75.56 | 78.49 | 3.72 % |
Bristol-Myers stock Forecast for 2027
| Month | Rate Forecast | MIN Rate | MAX Rate | Volati- lity, % |
|---|---|---|---|---|
| Jan | 75.69 | 72.49 | 78.31 | 7.44 % |
| Feb | 74.48 | 72.56 | 77.23 | 6.05 % |
| Mar | 74.24 | 71.22 | 75.67 | 5.88 % |
| Apr | 75.87 | 74.87 | 78.79 | 4.98 % |
| May | 74.20 | 73.10 | 75.51 | 3.19 % |
| Jun | 75.39 | 72.48 | 76.21 | 4.90 % |
| Jul | 74.60 | 72.50 | 76.48 | 5.20 % |
| Aug | 73.28 | 70.70 | 75.66 | 6.55 % |
| Sep | 77.07 | 76.06 | 78.47 | 3.08 % |
| Oct | 75.89 | 73.09 | 77.51 | 5.71 % |
| Nov | 75.26 | 72.98 | 77.50 | 5.82 % |
| Dec | 76.87 | 73.53 | 79.16 | 7.10 % |
Bristol-Myers overview
Bristol-Myers Address
430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, USMarket Capitalization
122 295 919 000 $EBITDA
18 692 999 000PE Ratio
15.57PEG Ratio
2.437Dividend Per Share
2.25Dividend Yield
0.0385EPS
3.76Quarterly Earnings Growth YOY
0.5Quarterly Revenue Growth YOY
-0.056Trailing PE
15.57Forward PE
9.97EV To Revenue
4.251EV To EBITDA
10.2952 Week High
79.4452 Week Low
58.3350 Day Moving Average
61.21200 Day Moving Average
67.17Shares Outstanding
2089100000Shares Float
Shares Short Prior Month
Short Ratio
Percent Insiders
Percent Institutions
Other Healthcare sector assets
| Name | Symbol | Last Close Price | Change |
|---|---|---|---|
 Abbott Laboratories
|
ABT | 107.28 (19.07.2023) | 0.31 % |
 AbbVie Inc.
|
ABBV | 137.68 (19.07.2023) | 0.81 % |
 Aeterna Zentaris Inc.
|
AEZS | 2.87 (14.07.2023) | -1.03 % |
 Allakos Inc.
|
ALLK | 4.65 (14.07.2023) | -2.11 % |
 Allogene Therapeutics, Inc.
|
ALLO | 4.96 (14.07.2023) | -4.89 % |
 Amgen Inc.
|
AMGN | 232.57 (18.07.2023) | 2.08 % |
|
Aphria Inc.
|
APHA | 15.38 (07.05.2021) | 0.00 % |
 Atara Biotherapeutics, Inc.
|
ATRA | 1.83 (14.07.2023) | -8.04 % |
 Aurora Cannabis Inc.
|
ACB | 0.534 (14.07.2023) | -5.94 % |
 Becton Dickinson and Company
|
BDX | 259.39 (14.07.2023) | -0.22 % |
 Biogen Inc.
|
BIIB | 278.4 (17.07.2023) | -0.19 % |
 Biohaven Pharmaceutical Holding Company Ltd.
|
BHVN | 26.24 (18.07.2023) | -0.64 % |
 BioNTech SE
|
BNTX | 109.13 (19.07.2023) | 0.91 % |
 bluebird bio, Inc.
|
BLUE | 3.03 (14.07.2023) | -8.46 % |
 Boston Scientific Corp.
|
BSX | 53.03 (14.07.2023) | 0.45 % |
|
Bristol-Myers Squibb Company
|
BMY | 61.85 (17.07.2023) | -0.15 % |
 Canopy Growth Corp.
|
CGC | 0.3841 (14.07.2023) | -40.91 % |
 Castle Biosciences, Inc.
|
CSTL | 16.83 (18.07.2023) | 2.00 % |
|
CLOVER HEALTH INVESTMENTS, CORP
|
CLOV | 3.16 (07.01.2022) | -5.67 % |
 Eli Lilly and Company
|
LLY | 242.27 (04.02.2022) | 0.00 % |
 Emergent BioSolutions Inc.
|
EBS | 7.21 (14.07.2023) | -0.96 % |
 Exelixis, Inc.
|
EXEL | 18.56 (17.06.2022) | 5.63 % |
 G1 Therapeutics, Inc.
|
GTHX | 2.41 (14.07.2023) | -0.82 % |
 Gilead Sciences, Inc.
|
GILD | 77.19 (14.07.2023) | 0.63 % |
 GlaxoSmithKline plc
|
GSK | 34.53 (14.07.2023) | -0.78 % |
 GoodRx Holdings, Inc.
|
GDRX | 7.46 (14.07.2023) | 1.77 % |
 GW Pharmaceuticals plc.
|
GWPH | 218.96 (05.05.2021) | 0.00 % |
 Incyte Corp.
|
INCY | 61.08 (17.07.2023) | -1.10 % |
 Inovio Pharmaceuticals, Inc.
|
INO | 0.5392 (17.07.2023) | 2.70 % |
 Johnson & Johnson
|
JNJ | 166.11 (13.04.2023) | 1.34 % |
 Medtronic plc.
|
MDT | 86.12 (19.07.2023) | -0.55 % |
 Merck & Co., Inc.
|
MRK | 105.57 (17.07.2023) | -1.65 % |
 Moderna, Inc.
|
MRNA | 121.35 (14.07.2023) | -4.15 % |
 Novartis AG
|
NVS | 98.83 (14.07.2023) | 0.51 % |
 Novavax, Inc.
|
NVAX | 8.68 (14.07.2023) | -6.06 % |
 ObsEva SA
|
OBSV | 0.05 (14.07.2023) | 0.00 % |
 OrganiGram Holdings Inc.
|
OGI | 1.49 (17.07.2023) | -4.49 % |
 Pfizer Inc.
|
PFE | 35.86 (17.07.2023) | -1.27 % |
 Regeneron Pharmaceuticals, Inc.
|
REGN | 721.61 (17.07.2023) | 0.43 % |
 Sanofi
|
SNY | 52.68 (14.07.2023) | 1.07 % |
 Schrodinger, Inc.
|
SDGR | 55.01 (18.07.2023) | 0.88 % |
 Senseonics Holdings, Inc.
|
SENS | 0.875 (14.07.2023) | -3.90 % |
 Sorrento Therapeutics, Inc.
|
SRNE | 0.35 (14.07.2023) | -0.28 % |
 Stryker Corp.
|
SYK | 298.62 (17.07.2023) | -1.26 % |
 Sundial Growers Inc.
|
SNDL | 1.42 (17.07.2023) | 1.43 % |
 Teva Pharmaceutical Industries Lim. (TEVA)
|
TEVA | 8.56 (19.07.2023) | 5.29 % |
 Thermo Fisher Scientific Inc.
|
TMO | 535.55 (19.07.2023) | 2.27 % |
 Tilray, Inc.
|
TLRY | 1.69 (17.07.2023) | 1.81 % |
 UnitedHealth Group, Inc.
|
UNH | 480.17 (14.07.2023) | 7.24 % |
 Veeva Systems Inc.
|
VEEV | 206.17 (19.07.2023) | -1.52 % |
|
Zomedica Corp.
|
ZOM | 0.2114 (14.07.2023) | -5.41 % |
 Zynerba Pharmaceuticals, Inc.
|
ZYNE | 0.371 (19.07.2023) | 1.64 % |
Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post.php on line 1205
Denial of responsibility:
The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.